AI breast cancer diagnosis technology approved for UK and EU

The breast cancer diagnosis technology – called PANProfiler – has been developed by Panakeia and can accurately predict biomarker status from digitally imaged routine pathology samples. The technology has received UKCA and CE certification for clinical use by health services in the UK and EU. Read more

A new AI-based test that can predict the most effective treatment from images of routine cancer samples has been approved for use in the UK and EU, speeding up diagnosis and reducing the need for lab